We are live on ! Find out more
Bronte Capital Management

Bronte Capital Management Portfolio holdings

AUM $997M Turnover 3.45%
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+3.72%
1 Year Est. Return
+24.2%
3 Year Est. Return
+122.24%
5 Year Est. Return
+145.26%
10 Year Est. Return
–
AUM
$997M
AUM Growth
+$65.9M
Cap. Flow
+$25.7M
Cap. Flow %
2.57%
Top 10 Hldgs %
71.36%
Holding
58
New
1
Increased
32
Reduced
7
Closed
1
Avg Time Held Equity + Options
2.1 years
Top 10 Avg Time Held Equity + Options
3.6 years
Top 20 Avg Time Held Equity + Options
3 years
Avg Time Held Equity only
2.1 years
Top 10 Avg Time Held Equity only
3.7 years
Top 20 Avg Time Held Equity only
3.4 years

Sector Composition

Rank Sector Weight
1 Financials 21.58%
2 Miscellaneous 18.33%
3 Healthcare 15.1%
4 Communication Services 14.22%
5 Consumer Staples 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
REGN icon
1
Regeneron Pharmaceuticals
REGN
$95.2B
$125M 12.55%
165,070
+2,452
+2% +$1.85M
2020 Q4
23 quarters
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$3.26T
$101M 10.16%
294,414
-10,751
-4% -$3.73M
2018 Q4
31 quarters
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.21T
$76.2M 7.64%
152,978
+7,131
+5% +$3.6M
2018 Q4
31 quarters
IBKR icon
4
Interactive Brokers
IBKR
$32.3B
$75.1M 7.54%
879,553
-3,973
-0.4% -$364K
2018 Q4
31 quarters
AMZN icon
5
Amazon
AMZN
$2.67T
$68.1M 6.83%
273,201
+11,768
+5% +$2.99M
2023 Q1
14 quarters
PM icon
6
Philip Morris
PM
$287B
$58.2M 5.84%
304,952
+4,776
+2% +$902K
2021 Q3
20 quarters
REGN icon
7
CALL
Regeneron Pharmaceuticals
REGN
$95.2B
$52M 5.22%
68,600
– –
2025 Q4
3 quarters
DIS icon
8
Walt Disney
DIS
$202B
$40.5M 4.06%
385,659
+25,416
+7% +$2.6M
2026 Q1
2 quarters
CTVA icon
9
Corteva
CTVA
$5.27B
$36.1M 3.62%
464,308
+7,652
+2% +$633K
2019 Q3
28 quarters
COF icon
10
Capital One
COF
$107B
$34.1M 3.42%
176,737
+3,214
+2% +$674K
2025 Q2
5 quarters
FCNCA icon
11
First Citizens BancShares
FCNCA
$23B
$29.7M 2.98%
14,417
+238
+2% +$512K
2023 Q1
14 quarters
TBBB icon
12
BBB Foods
TBBB
$7.82B
$28.6M 2.86%
542,490
+9,339
+2% +$431K
2025 Q4
3 quarters
IHG icon
13
InterContinental Hotels
IHG
$24.7B
$21.7M 2.18%
+134,324
New +$21.4M
2026 Q3
0 quarters
IBB icon
14
iShares Biotechnology ETF
IBB
$10.4B
$13.9M 1.4%
66,212
+405
+0.6% +$81.3K
2022 Q2
17 quarters
BF.B icon
15
Brown-Forman Class B
BF.B
$13.7B
$13.9M 1.39%
529,314
+65,001
+14% +$1.75M
2026 Q2
1 quarter
GHC icon
16
Graham Holdings
GHC
$5.22B
$13.2M 1.33%
11,653
+199
+2% +$232K
2020 Q3
24 quarters
NKTR icon
17
Nektar Therapeutics
NKTR
$1.03B
$12.2M 1.23%
202,057
+3,623
+2% +$254K
2026 Q1
2 quarters
GLBE icon
18
Global E Online
GLBE
$5.68B
$9.2M 0.92%
231,450
+3,806
+2% +$148K
2026 Q1
2 quarters
ALNY icon
19
Alnylam Pharmaceuticals
ALNY
$19.3B
$8.81M 0.88%
35,708
+324
+0.9% +$82.5K
2025 Q3
4 quarters
NEM icon
20
Newmont
NEM
$98.4B
$8.1M 0.81%
70,213
+719
+1% +$80.5K
2025 Q2
5 quarters
SQM icon
21
Sociedad Química y Minera de Chile
SQM
$13.4B
$7.61M 0.76%
117,370
+1,062
+0.9% +$76.7K
2021 Q4
19 quarters
B icon
22
Barrick Mining
B
$51.4B
$6.01M 0.6%
147,771
+1,412
+1% +$57.9K
2025 Q2
5 quarters
AUR icon
23
Aurora
AUR
$7.07B
$5.21M 0.52%
940,111
-1,246,710
-57% -$7.84M
2026 Q1
2 quarters
RSKD icon
24
Riskified
RSKD
$1.26B
$4.75M 0.48%
600,398
+12,147
+2% +$71.8K
2022 Q3
16 quarters
HLF icon
25
Herbalife
HLF
$1.63B
$4M 0.4%
329,397
+6,011
+2% +$73.9K
2018 Q4
31 quarters

Similar funds

Bronte Capital Management's Q3 2026 Portfolio in Review

As of Q3 2026, Bronte Capital Management held 58 positions worth $997M, up 7.1% from $931M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Trading was light in Q3 2026: portfolio turnover was 3.4%. Bronte Capital Management opened 1 new position and exited 1, leaving the 58-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Miscellaneous and Healthcare.

  • Bronte Capital Management's largest Q3 2026 buy was InterContinental Hotels: 134,324 shares worth $21.7M.
  • Bronte Capital Management added most to Berkshire Hathaway Class B in Q3 2026, an estimated $3.6M increase.
  • Bronte Capital Management's biggest Q3 2026 reduction was Aurora, cutting an estimated $7.84M.
  • Bronte Capital Management fully exited Gossamer Bio in Q3 2026, selling an estimated $11.2K.
  • Bronte Capital Management's ten largest holdings make up 71% of its $997M portfolio in Q3 2026.
  • Bronte Capital Management opened 1 new position and closed 1 in Q3 2026.
  • Bronte Capital Management's portfolio value rose 7.1% quarter-over-quarter to $997M.

Based on Bronte Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.